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The crude hydroalcoholic extract from fruits of P. pubescens is widely used because of its anti-rheumatic,
antinociceptive and anti-inﬂammatory activities. Furanoditerpenes have a vouacapan skeleton and are
involved with the pharmacological activity of the oil extracted from P. pubescens fruits. Furanoditerpenes
methyl 6a-acetoxy-7b-hydroxyvouacapan-17b-oate and methyl 6a-hydroxy-7b-acetoxyvouacapan-17b-
oate from P. pubescenswere isolated and identiﬁed. The present study developed and validated a GC–MS-
SIM method for the separation and quantiﬁcation of vouacapan constituents in a semipuriﬁed extract
from P. pubescens fruits. The GC–MS analyses were carried out using a system equipped with a HP-5
capillary column (30 m0.25 mm). Temperature program: 100 1C (4 1C min1)–270 1C (5 min), injector
260 1C, detector 270 1C. Helium was used as the carrier gas (0.7 bar, 1 mL min1). The MS was taken at
70 eV. Scanning speed was 0.5 scans s1, from 50 to 650. Sample volume was 1 mL. Split 1:20. Analyses
for validation of methodology were conducted by GC–MS-SIM (Single Ion Monitoring), where the ions
monitored were 131, 145 and 146 (between 43 and 44.5 min), 105, 145 and 197 (from 44.5 to 45.3 min)
and 131, 178 and 312 (from 45.3 to 48.5 min).Validation of the analytical method was based on the
following parameters: linearity, robustness, limits of detection and quantiﬁcation, precision (within-day
and between-day variabilities), recovery and stability. The method was linear over a range of 12.81–
2.56 mgmL1 of vouacapan 1, 112.78–22.56 mg mL1 of vouacapan 2, and 333.34–66.67 mg mL1 of
vouacapans 3 and 4, with detection limits of 0.39, 3.45 and 9,44 mg mL1 and quantiﬁcation limits of
1.19, 10.47 and 28.62 mg mL1, respectively. Recovery values were 100.69%, 97.48% and 96.98% for
vouacapans 1, 2 and 3–4, respectively. Thus, the method was efﬁcient to separate and quantify
furanoditerpenes in the extract or fraction.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Trees of the genus Pterodon, commonly known as ‘‘sucupira
branca’’ or ‘‘faveiro,’’ are native to Brazil [1–3]. The crude hydro-
alcoholic extract from fruits of P. pubescens is widely used in folk
medicine because of its anti-rheumatic [4,5], antinociceptive
[6–8] and anti-inﬂammatory activities [9,10].
Furanoditerpenes have a vouacapan skeleton and are involved
with the pharmacological activity of the oil extracted from P.
pubescens fruits [7,9,11–13]. Transformation of plant raw materials
into a drug should aim to preserve the pharmacological and chemical
integrity of the plant, ensuring the constancy and security of its
biological effect and use, as well as its potential therapeutic value
[14]. Chemical integrity can be guaranteed by the standardization ofll rights reserved.
ringa, Centro de Cieˆncias da
, 5790 block K80, Zona Sete,
5; fax: þ55 44 30115050.
valho Cardoso).analytical techniques, which in turn must be evaluated and validated
to meet the requirements of analytical applications for experimental
studies, ensuring the reliability of results [15].
Although the biological effects of oil from P. pubescens fruits are
scientiﬁcally proven, analytical methodologies have not yet been
developed to quantify furanoditerpenes in extracts from plants of
this genus. The present study developed and validated a GC–MS-SIM
method for the separation and quantiﬁcation of vouacapan consti-
tuents in a semipuriﬁed extract from P. pubescens fruits. The main
validation parameters of the methods were also determined.2. Experimental
2.1. Chemicals and reagents
Chromatography Column: Silica gel 60 (Merck, 70–230 mesh)
and Sephadexs LH-20 (Pharmacia); Silica gel plates F254
(Merck, 0.25 mm thick). The crystals isolated from subfractions
A (1) and B (2) of the hexane fraction, with a purity of 97.3% and
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identiﬁed from subfraction C as methyl 6a-acetoxy-7b-hydroxy-
vouacapan-17b-oate (3) and methyl 6a-hydroxy-7b-acetoxy-
vouacapan-17b-oate (4), with a purity of 98%, were used as
standards for validation of the analytical methodology.
2.2. Apparatus
1H NMR (300 MHz) and 13C NMR (75 MHz): Varian Gemini 300
(7.05T) spectrometers in CDCl3, internal standard TMS (
1H NMR)
and solvent signal (13C NMR); GC–MS-Thermo Electron Corpora-
tion DSQ II; TLC.
2.3. Plant material
Pterodon pubescens Benth. fruits from Nossa Senhora do
Livramento, Mato Grosso, Brazil (151890 S; 561410 W) were
collected in May 2010. The specimen was identiﬁed by
Dr. Germano Guarim Neto from the Herbarium of the Federal
University of Mato Grosso, and the voucher specimen was
deposited in the Herbarium of Maringa´ State University, under
no. 20502.
2.4. Extraction and isolation of the constituents
The dried fruits (30 g) were extracted with 600 mL of ethanol
by turbo extraction (Ultra-Turrax UTC115KT, IKA Works,
Wilmington, NC, USA) and were ﬁltered. The ﬁltrate was added
to 700 mL of water and partitioned with 700 mL of hexane,
dichloromethane and ethyl acetate. The organic solvent was
evaporated in a vacuum evaporator and the aqueous fraction
was lyophilized to yield the hexane fraction (FH) (5.70 g), dichlor-
omethane fraction (FD) (0.76 g), ethyl acetate fraction (FEAc)
(0.44 g) and aqueous fraction (FA) (1.07 g).
The FH (5 g) was chromatographed in a column with Silica Gel
60 (70–230 mesh ASTM) eluted with 150 mL of hexane, hexa-
ne:ethyl acetate (9:1; 8:2; 7:3; 6:4; 1:1 and 2:8), ethyl acetate
and methanol, affording 114 fractions. The fractions were ana-
lyzed by TLC, affording 24 subfractions. Fraction 20 (0.36 g) was
puriﬁed on a Sephadex LH-20 gel eluted with methanol:chloro-
form (1:1) to yield subfractions A (2.1 mg), B (7.4 mg) and C
(20.7 mg). The compounds present in subfractions A and B were
not identiﬁed. However, the majority compound from the FH
fractions was identiﬁed as 14,15-epoxygeranylgeraniol.
Methyl 6a-acetoxy-7b-hydroxyvouacapan-17b-oate (3) white
solid;. EI-MS, m/z (rel. int.): 404 [M]þ . (2), 344(30), 313(28),
312(96), 269(27), 183(42), 178(70), 171(32), 163(29), 159(25),
157(25), 153(26), 152(25), 147(26), 146(26), 145(54), 137(33),
133(30), 131(100), 123(60), 121(44), 119(61), 117(26), 115(26),
109(54), 107(30), 105(34), 95(70), 93(30), 91(69), 85(28), 81(58),
79(26), 71(35), 69(71), 57(31), 55(54); 1H NMR (300 MHz, CDCl3)
dH 7.24 (s; H-16), 6.17 (d, J¼1.8 Hz; H-15), 5.23 (dd, J¼11.4 and
9.0 Hz; H-6), 3.73 (s; OCH3), 3.43–3.40 (m; H-14), 3.34 (dd,
J¼19.8 and 9.9 Hz; H-7), 2.66 (m; H-11b), 2.48 (m; H-11a), 2.39
(m; H-8), 2.03 (s; OCOCH3), 1.70 (m; H-1b), 1.50 (m; H-2), 1.43
(m; H-9), 1.43 (m; H-3b), 1.32 (d, J¼11.4 Hz; H-5), 1.22 (m;
H-3a), 1.09 (s; H-20), 1.03 (s; H-18), 0.99 (m; H-1a) and 0.95 (s;
H-19). 13C NMR (75 MHz, CDCl3) dC 175.67 (C-17), 172.20
(OCOCH3), 150.68 (C-12), 141.66 (C-16), 113.56 (C-13), 108.67
(C-15), 81.53 (C-7), 75.71 (C-6), 55.12 (C-5), 52.50 (OCH3), 48.09
(C-9), 46.50 (C-14), 43.56 (C-3), 42.72 (C-8), 39.44 (C-1), 38.91 (C-
10), 36.42 (C-18), 33.33 (C-4), 22.69 (C-19), 22.16 (C-11), 22.03
(OCOCH3), 18.48 (C-2) and 15.67 (C-20).
Methyl 6a-hydroxy-7b-acetoxyvouacapan-17b-oate (4) white
solid;. EI-MS, m/z (rel. int.): 404 [M]þ . (2), 313(26), 312(100),
269(28), 267(27), 183(42), 178(52), 171(33), 147(31), 146(25),145(57), 137(31), 133(31), 131(94), 123(56), 121(46), 119(58),
118(32), 109(56), 107(34), 105(36), 95(60), 93(29), 91(78),
83(25), 81(61), 79(26), 77(28), 69(75), 67(28), 55(50); 1H NMR
(300 MHz, CDCl3) dH 7.24 (s; H-16), 6.37 (d, J¼1.8 Hz; H-15), 5.42
(dd, J¼11.7 and 8.7 Hz; H-6), 4.12 (dd, J¼14.4 and 7.2 Hz; H-7),
3.73 (s; OCH3), 3.43-3.40 (m; H-14), 2.66 (m; H-11b), 2.48 (m;
H-11a), 2.39 (m; H-8), 2.04 (s; OCOCH3), 1.70 (m; H-1b), 1.50 (m;
H-2), 1.43 (m; H-9), 1.43 (m; H-3b), 1.36 (m; H-5), 1.22 (m; H-
3a), 1.09 (s; H-20), 1.03 (s; H-18), 0.99 (m; H-1a), and 0.95
(s; H-19). 13C NMR (75 MHz, CDCl3) dC 175.67 (C-17), 172.20
(OCOCH3), 150.68 (C-12), 141.66 (C-16), 113.56 (C-13), 107.44
(C-15), 81.53 (C-7), 74.28 (C-6), 54.22 (C-5), 52.50 (OCH3), 48.09
(C-9), 46.50 (C-14), 43.56 (C-3), 42.72 (C-8), 39.44 (C-1), 38.91
(C-10), 36.42 (C-18), 33.33 (C-4), 22.69 (C-19), 22.16 (C-11), 22.03
(OCOCH3), 18.48 (C-2) and 15.67 (C-20).
14,15-epoxygeranylgeraniol yellow oil; EI-MS, m/z (rel. int.):
288 [MH2O] (2), 119(27), 107(35), 25(26), 93(64), 81(100),
79(38), 71(63), 70(47), 68(30), 55(33); 1H NMR (300 MHz, CDCl3)
dH 5.41 (td, J¼6.9 and 1.2 Hz; H-2), 5.13 (2 H; m; H-6, H-10), 4.15
(d, J¼6.9 Hz; H-1), 2.71 (t, J¼6.3 Hz; H-14), 2.05 (3 H; m; H-4,
H-8, H-12), 1.64 (3 H; m; H-5, H-9, H-13), 1.60 (s; H-80), 1.30 (2 H;
s; H-16, H-160) and 1.26 (2 H; s; H-40, H-120). 13C NMR (75 MHz,
CDCl3) dC 139.91 (C-3), 135.42 (C-7), 134.25 (C-11), 125.02 (C-10),
124.09 (C-6), 123.56 (C-2), 64.45 (C-14), 59.60 (C-1), 57.49 (C-15),
39.80 (C-4), 39.73 (C-8), 36.50 (C-12), 27.65 (C-13), 26.75 (C-9),
26.45 (C-5), 25.11 (C-16), 25.11 (C-160), 18.95 (C-40), 18.55 (C-120)
and 16.22 (C-80).2.5. Analysis by GC–MS
The GC–MS analyses were carried out using a system equipped
with a HP-5 capillary column (30 m0.25 mm). Temperature
program: 100 1C (4 1C min1)–270 1C (5 min), injector 260 1C,
detector 270 1C. Helium was used as the carrier gas (0.7 bar,
1 mL min1). The MS was taken at 70 eV. Scanning speed was
0.5 scans s1, from 50 to 650. Sample volume was 1 mL. Split 1:20.
The samples were diluted in chloroform.
Analyses for validation of methodology were conducted by
GC–MS-SIM (Single Ion Monitoring), where the ions monitored
were 131, 145 and 146 (between 43 and 44.5 min), 105, 145 and
197 (from 44.5 to 45.3 min) and 131, 178 and 312 (from 45.3 to
48.5 min).2.6. Method validation
The method was validated according to the guidelines estab-
lished by the ICH (International Conference on the Harmonization
of Technical Requirements for the Registration of Pharmaceuticals
for Human Use) [15]. All results were expressed as percentages.
For the statistical analysis, the program Statisticaswas used. A 5%
level of signiﬁcance was selected.
The crystals isolated from subfractions A, B and C of FH,
showing a purity of 97.3% and 98% and identiﬁed as furanoditer-
penes, were used as standards for validation of the analytical
methodology. A mixture of subfractions A (2.79%), B (24.57%) and
C (72.64%) was used as the analytical standard.2.6.1. Linearity
The calibration curve was constructed in triplicate, using seven
levels of concentration between 12.81 and 2.56 mgmL1 of
vouacapan 1, 112.78 and 22.56 mg mL1 of vouacapan 2, and
333.34 and 66.67 mg mL1 of vouacapans 3 and 4. The slope and
other statistics of the calibration curves were calculated by linear
regression.
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The limit of detection (LOD) and limit of quantiﬁcation (LOQ)
were calculated based on the standard deviation (SD) and the
slope (S) of the calibration curves, using Eqs. (1) and (2).
LOD¼ 3:3ðSD=SÞ ð1Þ
LOQ ¼ 10ðSD=SÞ ð2Þ
2.6.3. Precision
A stock solution of FH was prepared and diluted in three
concentrations (0.4 mg mL1, 0.2 mg mL1 and 0.1 mg mL1).
Each concentration was prepared independently in triplicate.
Repeatability was assessed by the amount of furanoditerpenes
obtained at each concentration. After 12 days, the procedure was
repeated for evaluation of the intermediate precision. The relative
standard deviation (RSD) was calculated for repeatability and
intermediate precision.2.6.4. Accuracy
Recovery was evaluated by the standard addition method,
adding the mixture of vouacapans isolated in three different
known concentrations to the extractive solution of FH. All con-
centrations were prepared independently in three replicates. The
recovery data were determined by dividing the value obtained for
the sample prepared with the added standards, by the amount
added, and then multiplying by 100% [15].2.6.5. Robustness
Robustness was assessed by changing the initial temperature
of the oven from 60 1C min1 to 270 1C (5 min), with an increase
of 4 1C. The temperatures of the injector and detector were kept at
260 1C and 270 1C, respectively.2.6.6. Stability
A standard solution of vouacapans from P. pubescens, with
known concentration, was stored at 20 1C for 12 days and
analyzed by GC–MS. To be considered stable, the analytes should
remain chemically unchanged during the period.RT: 9.38 - 48.53
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Fig. 1. Chromatographical proﬁle of FH of P3. Results and discussion
After preparation of the ethanolic extract and its partition, the
subsequent experiments used only the hexane fraction (FH), since
it is beyond the high yield shown, and its low polarity, which
facilitates the extraction of nonpolar compounds such as diterpenes.
GC–MS analysis of FH (Fig. 1) showed the presence of a predominant
compound with retention time of 34.41 min, which was identiﬁed
using NMR as 14,15-epoxygeranylgeraniol. This diterpenoid was
previously isolated and identiﬁed by Mors et al. [18] and was
effective as a chemoprophylactic against schistosomiasis.
Because of a lack of commercially available reference stan-
dards, several chromatographic techniques were employed to
isolate furanic diterpenes present in the FH of P. pubescens fruits.
Subfractions A, B and C of FH were used as analytical standards to
validate the analytical method. The retention time of vouacapan 1
(isolated from subfraction A), 2 (from subfraction B) and 3–4
(from subfraction C), as well as the mass spectrum, was used to
identify the peak in the P. pubescens extractive solutions (Fig. 2).
Compound 4 was previously identiﬁed by Fascio et al. [17] in
P. pubescens. However, compound 3 has so far been identiﬁed only
in the species P. apparicioi and P. polygalaeﬂorus [16,17]. This is
the ﬁrst identiﬁcation of methyl 6a-acetoxy-7b-hydroxyvouaca-
pan-17b-oate (3) in P. pubescens.
Inspection of the fragmentation data revealed that the frag-
ments generated by compounds 3 and 4 were identical, varying
only in intensity, which is a strong indication of isomerism. These
data were conﬁrmed from the NMR spectra, where the com-
pounds from subfraction C were identiﬁed as methyl 6a-acetoxy-
7b-hydroxyvouacapan-17b-oate (3) and methyl 6a-hydroxy-7b-
acetoxyvouacapan-17b-oate (4) by comparison of experimental 1H
and 13C-NMR spectroscopy, g HSQC and g HMBC spectral analysis,
and comparison of literature data [16,17]. Compound (4) was
characterized by the presence of an acetoxyl group at C-7 and the
hydroxyl function at C-6. Acetylation at position 6 in compound (3)
resulted in modest downﬁeld shifts in the range of 0.9 ppm–
1.43 ppm compared with compound (4) C-5 [Ddc¼55.12 (3)–54.22
(4)¼0.9 ppm], C-6 [Ddc¼75.71 (3)–74.28(4)¼1.43 ppm].
Since they are isomers of position, the GC–MS analysis did not
show good resolution in the separation of compounds 3 and 4,
which had overlapping peaks. Therefore these were considered as30 32 34 36 38 40 42 44 46 48
e (min)
34.41
44.76
46.2936.63
48.0244.17
38.40 40.4633.1329.15 31.35
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terodon pubescens obtained by GC–MS.
Fig. 2. Chromatogram of furanic diterpenes isolated from FH. Vouacapans 1 (retention time: 44.22), 2 (retention time: 44.83) and 3–4 (retention time: 46.10 and 46.36).
Table 1
Overview of the results about the calibration model.
Vouacapan 1 Vouacapan 2 Vouacapan 3–4
Range (mg/mL) 12.81–2.56 112.78–22.56 333.34–66.67
Number of standards 7 7 7
Correlation coefﬁcient 0.9924 0.9924 0.9935
Intercept7standard error 48472.32710923.42 749194.837107334.2 1610689.557288015.7
Slope7standard error 91752.1871839.32 102540.672052.8 100632.4271863.7
F cal. regres. (F crit.¼4.38) 2488 2495 2915
F cal. residue (F crit.¼2.96) 0.79 0.57 0.51
D.L. (mg/mL) 0.39 3.45 9.44
Q.L. (mg/mL) 1.19 10.47 28.62
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the total area of the furanoditerpenes present in the standard.
Compounds 1 and 2 were not identiﬁed because they were
present in small quantities in the sample (2.79% and 24.57%,
respectively) and were not detected by NMR. However, fragmen-
tation is not a randomized process. It can be predicted and is
related to the charge location, the cleavage mechanisms, and the
stability of the compound, allowing interpretation of the spec-
trum [19]. The mass spectra of peaks 1 and 2 indicated that these
compounds belong to the class of furanoditerpenes. The accurate
identiﬁcation of these compounds is being investigated.
Knowledge of the amount of the compound of interest in the
sample, the variability of this content due to climate and season
of collection, and the lack of commercially available reference
compounds are the main challenges for the development of new
quantitative methods for determination of compounds present in
medicinal plants. The creation of a new method involves both
development and validation of the proposed methodology [20].
For qualitative and quantitative analysis of FHPp, an analytical
method for determination of furanic diterpenes was developed.
GC–MS-SIM analysis was proposed, because this method is
commonly used to detect furanoditerpenes. Gas chromatography
allows a prior separation of the constituents of the sample, which
provides some speciﬁcity in the assay of the constituents of
extracts and/or herbal drugs, as these are not analyzed as a
mixture, but rather singly or in less-complex mixtures.
After this separation, each constituent is analyzed indivi-
dually by mass spectrometry. The selected ion monitoringallows a more sensitive and accurate assay, which ensures more
accurate and reliable qualitative and quantitative analytical
results [21].
The linearity was examined by the analysis of vouacapans 1, 2
and 3–4 at seven concentration levels (12.81–2.56 mgmL1 of
vouacapan 1, 112.78–22.56 mg mL1 of vouacapan 2 and 333.34–
66.67 mg mL1 of vouacapans 3–4). The curves showed an excellent
correlation coefﬁcient (r). The regression model was signiﬁcant for
the three analytical curves. The lack of ﬁt of the linear model was
also analyzed, demonstrating that the model is adjusted. The LOD,
the lowest absolute concentration of the analyte in a sample that can
be detected, but not necessarily quantiﬁed in the experimental
condition, and the LOQ, the lowest concentration of analyte in a
sample that can be accurately determined and with acceptable
quantiﬁcation, were calculated (Table 1).
Precision was investigated at two levels: Repeatability (under
the same conditions over a short period of time) and intermediate
precision (the effect of carrying out analyses on different days).
The values obtained are summarized in Table 2.
According to the AOAC [22], values of the relative standard
deviation (RSD) up to 3.7%, 5.3% and 7.3% are accepted for testing
the precision of analyte concentrations of 0.1%, 100 ppm and 10 ppm,
respectively. For tests of repeatability and intermediate precision, the
concentrations 400 ppm (0.4 mgmL1), 200 ppm (0.2 mgmL1) and
100 ppm (0.1 mgmL1) had RSD values less than 5.22%, within the
maximum allowed (5.3%) for solutions at a concentration of 100 ppm.
These results demonstrate that the method has acceptable
repeatability and intermediate precision, regardless of the level
Table 2
Data on the precision of the method.
Concentration
(mg/mL)
Repeatability Intermediate precision
Mean7(mg/mL) S.D. R.S.D.
(%)
Mean (mg/mL)7S.D. R.S.D.
(%)
Vouacapan 1 (n¼3)
0.4 6.0770.00 2.20 5.9370.00 7.77
0.2 3.5070.00 4.28 3.5070.00 5.72
0.1 2.6370.00 4.65 2.6870.00 4.76
Vouacapan 2 (n¼3)
0.4 36.0770.00 2.13 36.8870.00 4.71
0.2 26.7570.00 2.22 27.9570.00 5.14
0.1 23.5670.00 1.64 23.4170.00 1.72
Vouacapan 3–4 (n¼3)
0.4 73.1370.00 1.67 69.3670.00 4.46
0.2 69.7570.00 2.72 66.3770.00 0.86
0.1 67.4770.00 0.39 64.6670.00 3.46
Table 3
Results of the recovery experiment.
Solution (n¼3) Mean of
determined
amount (mg/mL)
Theoretical
amount
(mg/mL)
Recovery7R.S.D.
(%)
Vouacapan 1a 2.21 2.17 101.6772.78
Vouacapan 1b 1.99 1.82 108.8171.86
Vouacapan 1c 1.43 1.56 91.5874.04
Vouacapan 2a 13.30 13.82 96.2170.74
Vouacapan 2b 13.48 12.74 105.8072.74
Vouacapan 2c 10.58 11.70 90.4472.84
Vouacapan 3–4a 35.68 39.02 91.4470.62
Vouacapan 3–4b 35.06 34.20 102.5170.74
Vouacapan 3–4c 29.63 32.53 91.0870.37
a Large amount of standard addition.
b Addition of intermediate quantity of standard.
c Addition of small amount of the FHPp standard solution.
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deviation less than 5%, as established by ICH [15]. Vouacapan 1
showed a wider variation, which can be explained by the low
concentration (2.79%) of this compound; however, the RSD of
vouacapan 1 did not exceed the limits set by the AOAC [22]. These
results can be considered satisfactory, since most herbal drugs
show coefﬁcients of variation of 3–6% [23]. Therefore, the method
showed accuracy for the FHPp derived vouacapan analysis.
Recovery was also evaluated at three levels, and mean recov-
eries were calculated (Table 3). Recovery was between 90% and
107%, indicating the accuracy of the analytical method for the
concentration of 100 ppm (0.1 mg mL1). These ﬁndings indicate
that this method is accurate for vouacapans 2–4, which showed
recoveries between 90.4% and 105.8%, within the range set by the
AOAC [between 91.5% and 108.81%, again within the AOAC limit
[22] of 80–110% for 22].
Similarly, vouacapan 1 showed recoveries solutions with a
concentration of 10 ppm (0.01 mg mL1).
The robustness of the method was tested by changing the
temperature of the device. The retention time of peaks 1, 2, 3 and
4 increased to 50.97, 51.85, 53.49 and 53.82 min, respectively.
With increasing temperature, generally the solubility of the
sample in the liquid phase is altered, decreasing the residence
time of the analyte in the liquid phase, which leads to a decrease
in residence time in the gas chromatograph [24]. The reverse
occurs when the temperature is decreased, explaining the longer
residence time of the compound in the liquid phase and theconsequent increase in retention time of the compounds. How-
ever, despite the increased retention time, the chromatographic
proﬁle did not change appreciably, indicating that the method is
robust and stable under small variations of the analytical para-
meters. To evaluate the stability, a sample was evaluated after 12
days, and the vouacapan-derived compounds remained chemi-
cally unchanged, indicating their stability.4. Conclusion
The diterpenes 14,15-epoxygeranylgeraniol; methyl 6a-acet-
oxy-7b-hydroxyvouacapan-17b-oate and methyl 6a-hydroxy-7b-
acetoxyvouacapan-17b-oate of Pterodon pubescens were isolated
and identiﬁed. The analytical method was validated according to
the ICH guidelines. In this study, the GC–MS-SIM method proved
to be sensitive, accurate, linear, precise, reproducible, repeatable,
and with robust stability. These results indicate that this method
is suitable for the determination of vouacapans in P. pubescens
extracts and oil fraction.Acknowledgment
The authors acknowledge CAPES and CNPq for ﬁnancial support.
References
[1] R.C. Dutra, R. Trevizani, F. Pittella, N.R. Barbosa, Lat. Am. J. Pharm. 27 (2008)
865–870.
[2] D. Hansen, M. Haraguchi, A. Alonso, Braz. J. Pharm. Sci. 46 (2010) 605–616.
[3] D.M.T. Oliveira, E.A.S. Paiva, Braz. J. Biol. 65 (2005) 483–494.
[4] M.G. Coelho, K.C. Sabino, S.R. Dalmau, Clin. Exp. Rheumatol. 22 (2004)
213–218.
[5] K.C. Sabino, F.A. Castro, J.C. Oliveira, S.R. Dalmau, M.G. Coelho, Phytother. Res.
13 (1999) 613–615.
[6] L.P. Coelho, P.A. Reis, F.L. Castro, C.R.M. Gayer, C.S. Lopes, M.C.C. Silva,
K.C.C. Sabino, A.R. Todeschini, M.G.P. Coelho, J. Ethnopharmacol. 98 (2005)
109–116.
[7] H.M. Spindola, L. Servat, C. Denny, R.A.F. Rodrigues, M.N. Eberlin, E. Cabral,
I.M.O. Sousa, J.Y. Tamashiro, J.E. Carvalho, M.A. Foglio, BMC Pharmacol. 10
(2010).
[8] H.M. Spindola, L. Servat, R.A.F. Rodrigues, I.M.O. Sousa, J.E. Carvalho,
M.A. Foglio, Eur. J. Pharmacol. 656 (2011) 45–51.
[9] J.C.T. Carvalho, J.A.A. Sertie´, M.V.J. Barbosa, K.C.M. Patrı´cio, L.R.G. Caputo,
S.J. Sarti, L.P. Ferreira, J.K. Bastos, J. Ethnopharmacol. 64 (1999) 127–133.
[10] R.C. Dutra, M.B. Fava, C.C. Alves, A.P. Ferreira, N.R. Barbosa, J. Pharm.
Pharmacol. 61 (2009) 243–250.
[11] E.A. Nunan, M.G. Carvalho, D. Piloveloso, Braz. J. Med. Biol. Res. 15 (1982)
450–451.
[12] M.C.C. Silva, C.R.M. Gayer, C.S. Lopes, N.O. Calixto, P.A. Reis, C.P.B. Passeas,
M.C. Paes, S.R. Dalmau, K.C.C. Sabino, A.R. Todeschini, M.G.P. Coelho, J. Pharm.
Pharmacol. 55 (2004) 135–141.
[13] H.M. Spindola, J.E. Carvalho, A.L.T.G. Ruiz, R.A.F. Rodrigues, C. Denny, I.M.O. Sousa,
J.Y. Tamashiro, M.A. Foglio, J. Braz. Chem. Soc. 20 (2009) 569–575.
[14] M.D. Miguel, O.G. Miguel, Desenvolvimento de ﬁtotera´picos, Robe, S~ao Paulo,
1999.
[15] International Conference on Harmonization, ICH Topic Q2 (R1) Validation of
analytical procedures: text and methodology. Available from: /http://www.
ich.orgS, 2005.
[16] A.M.C. Arriaga, M.A.B. Castro, E.R. Silveira, R. Braz-Filho., J. Braz. Chem. Soc. 11
(2000) 187–190.
[17] M. Fascio, W.B. Mors, B. Gilbert, J.R. Mahajan, M.B. Monteiro, D. Dos Santos
Filho, W. Vichnewski, Phytochemisty 15 (1976) 201–203.
[18] W.B. Mors, M. Fascio, H.J. Monteiro, B. Gilbert, J. Pellegrino, Science 157
(1967) 950–951.
[19] Agilent, Interpretation of Mass Spectra: Course Number H4063A, 2000, 253.
[20] Mart H.B.L. Theunis, K. Foubert, J. Pollier, M. Gonzales-Guzman, A. Goossens,
A.R. Vlietinck, L.A.C. Pieters, S. Apers, Phytochemistry 68 (2007) 2825–2830.
[21] C.F. Peng, H. Kaung, X.Q. Li, C.L. Xu, Chem. Pap. 61 (2007) 1–5.
[22] AOAC Peer Veriﬁed Methods Program , Manual on Policies and Procedures,
Arlington, VA, 1993.
[23] W. Andlauer, M.J. Martena, P. Furst, J. Chromatogr. A 849 (1999) 341–348.
[24] G.P. Sabin, 2007. Desenvolvimento e validac- ~ao de me´todo utilizando SPE
e CG-MS para a determinac- ~ao multirresı´duo de pesticidas em a´gua pota´vel,
Dissertac- ~ao, 2007.
